Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
ARS
2022 FY
Annual report to shareholders
26 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K/A
2022 FY
Annual report (amended)
27 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Current reports
8-K
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
25 Mar 24
8-K
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
21 Mar 24
8-K/A
Departure of Directors or Certain Officers
18 Mar 24
8-K/A
Departure of Directors or Certain Officers
18 Mar 24
8-K
Departure of Directors or Certain Officers
12 Feb 24
8-K
Regulation FD Disclosure
26 Jan 24
8-K
Entry into a Material Definitive Agreement
19 Jan 24
8-K/A
Departure of Directors or Certain Officers
5 Dec 23
8-K
Departure of Directors or Certain Officers
30 Nov 23
8-K
Regulation FD Disclosure
20 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
22 Mar 24
424B5
Prospectus supplement for primary offering
19 Jan 24
S-3
Shelf registration
22 Nov 23
424B3
Prospectus supplement
22 Aug 23
POS AM
Prospectus update (post-effective amendment)
18 Aug 23
424B3
Prospectus supplement
11 Aug 23
424B3
Prospectus supplement
25 Jul 23
424B3
Prospectus supplement
6 Jul 23
424B3
Prospectus supplement
23 Jun 23
424B3
Prospectus supplement
26 May 23
Proxies
DEF 14A
Definitive proxy
26 Apr 24
DEF 14A
Definitive proxy
26 May 23
DEFA14A
Additional proxy soliciting materials
8 Jul 22
DEFA14A
Additional proxy soliciting materials
6 Jul 22
DEFA14A
Additional proxy soliciting materials
23 Jun 22
DEFA14A
Additional proxy soliciting materials
15 Jun 22
DEFM14A
Proxy related to merger
10 Jun 22
DEFA14A
Additional proxy soliciting materials
8 Jun 22
DEFA14A
Additional proxy soliciting materials
7 Jun 22
DEFA14A
Additional proxy soliciting materials
26 May 22
Other
EFFECT
Notice of effectiveness
1 Dec 23
CORRESP
Correspondence with SEC
28 Nov 23
UPLOAD
Letter from SEC
27 Nov 23
EFFECT
Notice of effectiveness
22 Aug 23
EFFECT
Notice of effectiveness
21 Apr 23
EFFECT
Notice of effectiveness
9 Sep 22
CORRESP
Correspondence with SEC
6 Sep 22
CORRESP
Correspondence with SEC
26 Aug 22
UPLOAD
Letter from SEC
15 Aug 22
UPLOAD
Letter from SEC
17 May 22
Ownership
4
Darin J. Weber
23 Apr 24
144
Notice of proposed sale of securities
18 Apr 24
4
Darin J. Weber
17 Apr 24
4
Darin J. Weber
16 Apr 24
144
Notice of proposed sale of securities
16 Apr 24
144
Notice of proposed sale of securities
12 Apr 24
4
Ulrich Peter Alfred Ernst
2 Apr 24
3
Ulrich Peter Alfred Ernst
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
James Coulston
5 Mar 24